“…Carbapenemase production is the common carbapenemase resistance mechanism in clinical infections, such as Acinetobacter baumannii ( Oinuma et al, 2021 ), K. pneumoniae ( Pitout et al, 2015 ) and Pseudomonas aeruginosa ( Nordmann et al, 2011 ; Doi and Paterson, 2015 ; Iovleva and Doi, 2017 ). The main carbapenemase genes carried by K. michiganensis include bla KPC-2 , bla VIM-1 ( Campos-Madueno et al, 2021 ), bla NDM-1 ( Li et al, 2021 ), bla NDM-5 ( Zheng et al, 2018 ), bla KPC-3 ( Seiffert et al, 2019 ), bla IMP-4 ( Li et al, 2021 ; Zhang et al, 2021 ), bla OXA-181 ( Founou et al, 2018 ), bla SIM-1 , bla OXA-1 , bla CTX-M-14 ( Xu et al, 2022 ), etc.…”